Type 2 diabetes: treatment in 2024

Type 2 diabetes: treatment in 2024
Type 2 diabetes: treatment in 2024

A chronic disease, diabetes continues to see its prevalence increase (6.30% in 2022 compared to 5.6% in 2015). Its management has been revolutionized by the availability of new antidiabetic drugs (DPP-4 inhibitors, GLP-1 analogues, SGLT2 inhibitors): the therapeutic strategy can now be adapted to the patient’s profile and the desired objectives.

A selection of recent articles to keep up to date with the latest news, on the occasion of World Diabetes Day.

To read:

Nobile C. Type 2 diabetes: finally the new recommendations from the HAS! Rev. Prat (online) June 7, 2024.

Martin Agudelo L. Diabetic foot: new recipes. Rev. Prat (online) July 2, 2024.

Nobile C. New recommendations from the HAS on diabetes: reaction from the CNG. Rev. Prat (online) June 24, 2024.

Martin Agudelo L. Diabetes and CV risk: new findings from the ESC. Rev. Prat (online) December 7, 2023.

Duclos M. Type 2 diabetes: how to prescribe physical activity? Rev. Chat With Gen 2021 ;35(1056) ;200 – 1.

Martin Agudelo L. Sleeping in the dark to prevent diabetes. Rev. Prat (online) June 20, 2024.

Mallordy F. Type 2 diabetes and NAFLD: prefer gliflozins! Rev. Prat (online) March 5, 2024.

Foussard N. Complications of diabetes. Rev. Chat With Gen 2023 ;37(1081) ;453 – 61.

Martin Agudelo L. Nitrites (delicatessens): an increased risk of diabetes? Rev. Prat January 25, 2023.

Bordier L, Rouanet C, Diss J, et al. Type 2 diabetes in the elderly. Rev. Chat With Gen 2022 ;36(1068) ;281 – 4.

Mallordy F. Remission of diabetes: has metabolic surgery proven itself? Rev. Prat (online) September 27, 2022.

Amouyal C. Diabetes: has the ketogenic diet proven itself? Rev. Prat (online) August 25, 2022.

Rod A. Therapeutic education and type 2 diabetes. Rev. Chat With Gen 2022 ;36(1067) ;225 – 7.

Foussard N, Mohammedi K. Type 2 diabetes: the essentials. Rev. Chat With Gen 2022 ;36(1065) ;140 – 6.

Goin N, Gueguen J. High blood pressure and diabetes. Rev. Chat With Gen 2021 ;35(1062) ;486 – 8.

Potier L. Cardiovascular assessment in diabetics: should we screen for silent ischemia? Rev. Prat 2021 ;71(4) ;360 – 2.

Coito S. HbA1c: watch out for the pitfalls! Rev. Prat (online) November 5, 2024.

Martin Agudelo L. Less tension on GLP-1 analogues: evolution of recos. Rev. Prat (online) October 3, 2024.

-

-

PREV Type 2 diabetes: treatment in 2024
NEXT who should be tested?